API CAS 129722-12-9 Aripiprazole Pharmaceutical Raw Materials

Model NO.: CAS 129722-12-9
Trademark: dky
Transport Package: Aluminum Foil or Cardboard Barrels
Specification: Pharmaceutical grade
Origin: Dky
Model NO.: CAS 129722-12-9
Trademark: dky
Transport Package: Aluminum Foil or Cardboard Barrels
Specification: Pharmaceutical grade
Origin: Dky
API CAS 129722-12-9 Aripiprazole pharmaceutical raw materials

Aripiprazole
Synonyms: aripiprazole; aripiprazole deuterium -D8; aripiprazole D8; aripiprazole A; aripiprazole; aripiprazole; aripiprazole crystalline I, crystalline II, crystalline A (hydrate), crystalline B, crystalline C, crystalline D, crystalline E, crystalline F; aripiprazole crystalline II; aripiazole crystalline II; aripiazole
English Name: Aripiprazole
English synonyms: ARIPIPRAZOLE; ARIPIPRAZOLE-D8; ABILIFY; ABILITAT; 7-[4-[4- (2,3-dichlorophenyl) -1-piperazinyl]butoxy]-3,4-dihydrocarbostyril; OPC 14597; OPC 31; 7-[4-[4- (2,3-dichlorophenyl) -1-piperazinyl]butoxy]-3,4-dihydro-2.
CAS 129722-12-9
Molecular formula: C23H27Cl2N3O2
Molecular weight: 448.39
EINECS: 200-835-2
Melting point 139 C
Storage conditions -20 C Freezer
CAS database 129722-12-9 (CAS Database Reference)
Aripiprazole is a new type of highly lipophilic quinoline derivative. Its pharmacological characteristics are the postsynaptic dopamine D 2 receptor antagonist and the presynaptic dopamine D 2 receptor agonist. It also has the effect of stimulating D 1, D 3 and D 4 receptors; it has a double effect on the receptor antagonism or activation of the 5-HT 1A receptor, and has a complete antagonism to the 5-HT 2A receptor. This feature is different from the first and atypical antipsychotics, the second generation of antipsychotics, so it is known as a dopamine system stabilizer or the third generation of antipsychotic drugs. Since the last century, it has been mainly used in the treatment of schizophrenia, schizophrenic affective disorder and other psychotic disorders. According to the relevant literature, aripiprazole has a significant effect on the positive, negative symptoms, anxiety, depression and cognitive function of schizophrenia, and the safety is higher [1]. It is also reported that the drug can also be used to treat other mental disorders, such as affective disorder manic episodes, senile dementia with mental disorders, anxiety, children's behavioral disorders, and depression.
[content]: 99%
[packing]: 10kg/ cardboard barrel
[appearance]: white powder
API CAS 129722-12-9 Aripiprazole Pharmaceutical Raw Materials



  API CAS 129722-12-9 Aripiprazole pharmaceutical raw materials

Aripiprazole
Synonyms: aripiprazole; aripiprazole deuterium -D8; aripiprazole D8; aripiprazole A; aripiprazole; aripiprazole; aripiprazole crystalline I, crystalline II, crystalline A (hydrate), crystalline B, crystalline C, crystalline D, crystalline E, crystalline F; aripiprazole crystalline II; aripiazole crystalline II; aripiazole
English Name: Aripiprazole
English synonyms: ARIPIPRAZOLE; ARIPIPRAZOLE-D8; ABILIFY; ABILITAT; 7-[4-[4- (2,3-dichlorophenyl) -1-piperazinyl]butoxy]-3,4-dihydrocarbostyril; OPC 14597; OPC 31; 7-[4-[4- (2,3-dichlorophenyl) -1-piperazinyl]butoxy]-3,4-dihydro-2.
CAS 129722-12-9
Molecular formula: C23H27Cl2N3O2
Molecular weight: 448.39
EINECS: 200-835-2
Melting point 139 C
Storage conditions -20 C Freezer
CAS database 129722-12-9 (CAS Database Reference)
Aripiprazole is a new type of highly lipophilic quinoline derivative. Its pharmacological characteristics are the postsynaptic dopamine D 2 receptor antagonist and the presynaptic dopamine D 2 receptor agonist. It also has the effect of stimulating D 1, D 3 and D 4 receptors; it has a double effect on the receptor antagonism or activation of the 5-HT 1A receptor, and has a complete antagonism to the 5-HT 2A receptor. This feature is different from the first and atypical antipsychotics, the second generation of antipsychotics, so it is known as a dopamine system stabilizer or the third generation of antipsychotic drugs. Since the last century, it has been mainly used in the treatment of schizophrenia, schizophrenic affective disorder and other psychotic disorders. According to the relevant literature, aripiprazole has a significant effect on the positive, negative symptoms, anxiety, depression and cognitive function of schizophrenia, and the safety is higher [1]. It is also reported that the drug can also be used to treat other mental disorders, such as affective disorder manic episodes, senile dementia with mental disorders, anxiety, children's behavioral disorders, and depression.
[content]: 99%
[packing]: 10kg/ cardboard barrel
[appearance]: white powder
API CAS 129722-12-9 Aripiprazole Pharmaceutical Raw Materials



Â